MNNGF (Baijin Life Science Holdings) Total Assets: $36.18 Mil (As of Sep. 2025)


MNNGF Baijin Life Science Holdings Ltd MNNGF
36 GF Score
Price $0.08
GF Value $0.05
! 4 Warning Signs
View Full Analysis

What is Baijin Life Science Holdings Total Assets?

Baijin Life Science Holdings MNNGF 36 Total Assets is $36.18 Mil as of Sep. 2025. GuruFocus rates MNNGF with a GF Score™ of 36/100 and a GF Value™ of $0.05. The stock has 4 warning signs investors should review.

Baijin Life Science Holdings's Total Assets for the quarter that ended in Sep. 2025 was $36.18 Mil.

During the past 12 months, Baijin Life Science Holdings's average Total Assets Growth Rate was 16.60% per year. During the past 3 years, the average Total Assets Growth Rate was 60.60% per year. During the past 5 years, the average Total Assets Growth Rate was 18.40% per year. During the past 10 years, the average Total Assets Growth Rate was -7.60% per year.

During the past 13 years, Baijin Life Science Holdings's highest 3-Year average Total Assets Growth Rate was 60.60%. The lowest was -38.30%. And the median was -13.70%.

Total Assets is connected with ROA %. Baijin Life Science Holdings's annualized ROA % for the quarter that ended in Sep. 2025 was 1.52%. Total Assets is also linked to Revenue through Asset Turnover. Baijin Life Science Holdings's Asset Turnover for the quarter that ended in Sep. 2025 was 0.19.

Baijin Life Science Holdings  (OTCPK:MNNGF) Total Assets Explanation

Total Assets is connected with ROA %.

Baijin Life Science Holdings's annualized ROA % for the quarter that ended in Sep. 2025 is

ROA %=Net Income (Q: Sep. 2025 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=0.558/( (37.332+36.183)/ 2 )
=0.558/36.7575
=1.52 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Baijin Life Science Holdings's Asset Turnover for the quarter that ended in Sep. 2025 is

Asset Turnover
=Revenue (Q: Sep. 2025 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=7.084/( (37.332+36.183)/ 2 )
=7.084/36.7575
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Baijin Life Science Holdings Total Assets Related Terms

Baijin Life Science Holdings Total Assets Historical Data

* Premium members only.

The historical data trend for Baijin Life Science Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baijin Life Science Holdings Total Assets Chart

Baijin Life Science Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.50 12.72 25.16 37.33 33.79

Baijin Life Science Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.16 30.38 37.33 36.18 33.79
MNNGF
36GF Score
Baijin Life Science Holdings Ltd MNNGF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baijin Life Science Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Baijin Life Science Holdings's Total Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (A: Mar. 2025 )+Total Liabilities (A: Mar. 2025 )
=20.054+17.278
=37.33

Baijin Life Science Holdings's Total Assets for the quarter that ended in Sep. 2025 is calculated as

Total Assets=Total Equity (Q: Sep. 2025 )+Total Liabilities (Q: Sep. 2025 )
=20.273+15.91
=36.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $36.18 Mil mean?
Baijin Life Science Holdings (MNNGF) has a Total Assets of $36.18 Mil as of Sep. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Baijin Life Science Holdings and its competitors.
Is Baijin Life Science Holdings' Total Assets too high?
Baijin Life Science Holdings' current Total Assets is $36.18 Mil. Overall, Baijin Life Science Holdings has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Total Assets compare to TPR?
Baijin Life Science Holdings' Total Assets of $36.18 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Retail - Cyclical company?
A good Total Assets depends on the Retail - Cyclical industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Baijin Life Science Holdings and its competitors. Baijin Life Science Holdings's current Total Assets is $36.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Total Assets of $36.18 Mil. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 50% above its estimated fair value. The current Total Assets is $36.18 Mil. Baijin Life Science Holdings' overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Total Assets is $36.18 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?

Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued. The current stock price of $0.08 is trading 50% above its estimated GF Value™ of $0.05.

Key valuation signals for MNNGF:

  • Total Assets: $36.18 Mil
  • GF Value™: $0.05 vs. price of $0.08 (50% above fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baijin Life Science Holdings Business Description

Other Exchanges 01466:Hong Kong
Address 66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
36GF Score

Get the complete analysis for MNNGF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.05
GF Value